Chronic Bile Duct Injury Associated with Fibrotic Matrix Microenvironment Provokes Cholangiocarcinoma in p53-Deficient Mice
Open Access
- 1 July 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (13) , 6622-6627
Abstract
Intrahepatic cholangiocarcinoma (CCA) is a lethal malignancy of the biliary epithelium associated with p53 mutations, bile duct injury, inflammation, and fibrosis. Here, to validate these processes in CCA, we developed a liver cirrhosis model driven by chronic intermittent toxin exposure, which provokes bile duct injury/necrosis and proliferation, fibroblast recruitment, and progressive extracellular matrix (ECM) changes. Fibrotic changes in the matrix microenvironment, typified by increased type I and III collagens and fibroblast recruitment, were shown to stimulate biliary epithelium hyperplasia with subsequent progression to malignant intrahepatic CCA only in mice harboring a p53 mutant allele. These murine CCAs bear histologic and genetic features of human intrahepatic CCA, including dense peritumoral fibrosis, increased inducible nitric oxide synthase, nitrotyrosine, and cyclooxygenase-2 expression, c-Met activation, cErbB2 overexpression, down-regulation of membrane-associated E-cadherin, and p53 codon 248 mutation. Thus, p53 deficiency, chronic bile duct injury/proliferation, and the fibrotic matrix microenvironment cooperate to induce intrahepatic CCA, highlighting the key role of the ECM microenvironment in this common liver cancer. (Cancer Res 2006; 66(13): 6622-7) (Cancer Res 2006; 66(13): 6622-7)Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapyHepatology, 2005
- Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological ModelCritical Reviews in Toxicology, 2003
- Inflammation and cancerNature, 2002
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Expression of p53 and PCNA in Cholangiocarcinoma and Primary Sclerosing CholangitisLaboratory Investigation, 2000
- Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color bandingGenes, Chromosomes and Cancer, 2000
- New p53 mutations in hilar cholangiocarcinomaEuropean Journal of Clinical Investigation, 2000
- The Hallmarks of CancerCell, 2000
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994